AUA 2018 Bladder Cancer - Results from #20

Viewing 21-40 of 51 articles

AUA 2018: Treatment for MIBC for Cis-Platinum Ineligible Patients: Immediate Cystectomy

AUA 2018: Treatment for MIBC for Cis-Platinum Ineligible Patients: Other Systemic Options and Trials

AUA 2018: High Risk BCG Recurrent/Refractory Disease: Immediate Cystectomy

AUA 2018: Phase 3 Study of Vicinium in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: Initial Results

AUA 2018: Results of CALIBER: A Phase II Randomized Feasibility Trial of Chemoablation vs Surgical Management in Low Risk Non-Muscle Invasive Bladder Cancer

AUA 2018: Non-Surgical Management of Low Grade Upper Tract Urothelial Cancer: an Interim Analysis of the International Multicenter OLYMPUS Trial

AUA 2018: CG0070, an Oncolytic Adenovirus, for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: 12 Month Interim Results from a Multicenter Phase II Trial

AUA 2018: High Risk BCG Recurrent/Refractory Disease: Secondary Intravesical Therapy

AUA 2018: Adherence to Bladder Cancer Guidelines and Issues with Implementation

AUA 2018: Three Articles Last Year that Changed Practice: Bladder Cancer

AUA 2018: Where and How Does Cystoscopy Fall Short? Initial Results of a Prospective Cohort Study Evaluating Reliability of Endoscopic Evaluation in Predicting pT0 Disease at the Time of Radical Cystectomy

AUA 2018: Automated and Dynamic Classification of Bladder Cancer using Deep Learning on Real-Time Confocal Laser Endomicroscopy Images

AUA 2018: Translational Research to Potentiate Immunotherapy in Urothelial Cancer

AUA 2018: Refining Immunotherapy Combinations and Sequencing in Bladder Cancer

AUA 2018: Overview of Immunotherapy in GU Cancers

AUA 2018: Journal of Urology: Top Papers in Bladder and Renal Cancer

AUA 2018: Results of POUT - Phase III Randomized Trial of Peri-Operative Chemotherapy vs. Surveillance in Upper Tract Urothelial Cancer

AUA 2018: Racial Disparities in Quality of Care and Overall Survival among Muscle-Invasive Bladder Cancer Patients treated with Radical Cystectomy

AUA 2018: Neoadjuvant Pembrolizumab Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Interim Results from PURE-01

AUA 2018: Development of a Predictive Nomogram to Predict Overall Survival Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

1
2
3

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.